Drug & intervention
mitomycin
RxCUI 632
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Mitomycin C
Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
6 shownPhase II Trial of Lung ChemoemobolizationNCT05672108 · 2023-05-12
RECRUITINGTherapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerNCT04929028 · 2022-08-09
ACTIVE_NOT_RECRUITINGComparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.NCT03766425 · 2017-06-14
COMPLETEDComparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular CarcinomaNCT01171482 · 2015-11-01
TERMINATEDThe Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular CarcinomaNCT01953406 · 2015-11-01
WITHDRAWNRandomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.NCT00148395 · 2002-06-01
COMPLETEDConditions being studied
AIDS-Related Anal Carcinoma1Anal Margin Squamous Cell Carcinoma1Anal Non-Keratinizing Squamous Cell Carcinoma1Anal Squamous Cell Carcinoma1Carcinoma, Hepatocellular1Colon Cancer1Endobronchial Metastases1Eye Diseases1Glaucoma Surgery1Hepatocellular Carcinoma1HIV Infection1Lung Metastases From Any Primary1Lung Metastasis1Lung Non-Small Cell Carcinoma1Mediastinal Neoplasm1Non-Small-Cell Lung Carcinoma1Optic Nerve Damage1Pleural Neoplasm1Rectal Squamous Cell Carcinoma1Sarcoma1
Research locations
New YorkNew York, United States2SeoulSouth Korea2ChicagoIllinois, United States1DuarteCalifornia, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1St LouisMissouri, United States1TampaFlorida, United States1The BronxNew York, United States1Washington D.C.District of Columbia, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.